ChatGPT recommendations regarding atopic dermatitis (AD) often differ from AAAAI/ACAAI practice parameter recommendations.

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

May occur as a result of atopic and/or contact dermatitis. Arms, legs, back of the neck, backs of the hand, bottoms of the feet, scalp. Severe, chronic, and intense itching; thick, raised patches ...

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

The most common form of eczema is atopic dermatitis, and the terms are often used interchangeably. The condition often crops up during childhood, experts said. And while some people outgrow it ...

Top-line Phase 2b data anticipated for ANB032, our BTLA agonist, in atopic dermatitis (AD) in December 2024 Top-line ... will be crossed over to the high-dose rosnilimab treatment arm, in an ...

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

Positive results were announced from the ECZTEND extension study of Adbry in atopic dermatitis who took part in a previous parent trial.

As for safety, 49.4% of patients in the delgocitinib arm vs 76.1% of patients in ... by week 16 in the treatment of patients with atopic hand dermatitis," Armstrong reported.

Atopic dermatitis tends to appear on the extensor surfaces, face, and scalp in infants and around arm and leg creases in toddlers and older children. Severe forms of the condition can be more ...

Parents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can mean a heightened ...